Hepatitis G virus (HGV): where we stand and what to do?

ISSN： 1754-1441

Source： International Journal of Immunological Studies, Vol.1, Iss.3, 2011-08, pp. : 255-263

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

TNF blockade and cutaneous lupus erythematosus: where do we stand and where are we going?

By Zattra Edoardo Stan Roxana Russo Irene Lo Nigro Alessandro Peserico Andrea Alaibac Mauro

Immunotherapy, Vol. 5, Iss. 8, 2013-08 ,pp. : 791-794

Future Medicine

Access to resources Recommend Favorite

Prognostic biomarkers in colorectal cancer: where do we stand?

By Sagaert Xavier

Virchows Archiv, Vol. 464, Iss. 3, 2014-03 ,pp. : 379-391

Springer Publishing Company

Access to resources Recommend Favorite

Ex vivo expansion of umbilical cord blood: where are we?

By Aljitawi Omar

International Journal of Hematology, Vol. 95, Iss. 4, 2012-04 ,pp. : 371-379

Springer Publishing Company

Access to resources Recommend Favorite

The international arena of medical physics: where is Australasia?

By Suchowerska Natalka

Australasian Physical & Engineering Sciences in Medicine, Vol. 33, Iss. 2, 2010-06 ,pp. : 125-127

Springer Publishing Company

Access to resources Recommend Favorite

What is the status of gene therapy for primary immunodeficiency?

Immunologic Research, Vol. 38, Iss. 1-3, 2007-07 ,pp. : 274-284

Humana Press, Inc

Access to resources Recommend Favorite